What does PIDM mean in INTERNATIONAL
PIDM stands for the Programme for International Drug Monitoring, which is a global monitoring programme established by the World Health Organization (WHO) to harmonize and strengthen international drug regulation. The PIDM provides a global platform to enhance communication between regulatory authorities, healthcare professionals, scientists, and other stakeholders in order to ensure safe and effective medicines for all. Through this programme, quality standards are assured and information is exchanged throughout the world in order to expedite the resolution of safety issues relating to drugs.
PIDM meaning in International in International
PIDM mostly used in an acronym International in Category International that means Programme for International Drug Monitoring
Shorthand: PIDM,
Full Form: Programme for International Drug Monitoring
For more information of "Programme for International Drug Monitoring", see the section below.
What is PIDM?
The main function of the Programme for International Drug Monitoring (PIDM) is to ensure that medicines are safe, effective, high-quality, evidence-based and appropriate for their intended use. It aims to implement a unified drug monitoring system across countries with different regulatory requirements and contexts. This helps ensure that medicines meet the same standards everywhere in terms of efficacy, safety and quality. The WHO also works with regulatory authorities from around the world to facilitate exchange of information on drugs and possible risks associated with them. In addition, PIDM encourages public health initiatives through international collaboration on research projects, clinical trials, drug regulatory activities and education programmes.
How Does it Work?
The main goal of the Programme for International Drug Monitoring (PIDM) is to create a worldwide system of cooperation between relevant stakeholders such as regulatory authorities from countries as well as pharmaceutical companies. Through this system all stakeholders share information regarding existing drugs or new products that are developed so they can be properly assessed on their efficacy, safety profile and quality. This way everyone involved makes sure that only effective and safe medicines reach end users while still guaranteeing qualified access without compromising patient safety or being exposed to serious risks due to lack of knowledge about potential side effects or mislabeled dosages instructions. This oversight also extends beyond end users into research divisions where data sharing allows pharmaceutical companies time efficiency during clinical trials process as well as increased understanding from researchers about potentially risky factors associated with developing new drugs that must be taken into consideration before releasing them into general circulation.
Benefits
By having a coordinated international drug monitoring system like PIDM there are many tangible benefits including improved patient safety through higher quality standards enforced globally rather than locally; reduction in counterfeit medicine; faster reporting time due to more efficient information distribution systems; greater transparency in drug manufacturing processes; increased collaboration with all stakeholders involved; easier access for people living in remote areas or regions not served by traditional channels; potential reduction in healthcare costs due interactions between regulators throughout several jurisdictions; better informed decisions taken by health authorities and governments when approving new drugs for market release based on accumulated evidence from previous studies conducted outside their country borders; better public knowledge base regarding treatment options available since everyone has access to same amount of data no matter where they live or how much money they have available at any given moment - all these advantages make PIDM an invaluable tool when it comes maintaining proper levels of quality assurance related not only directly but indirectly affects everyone's life someday one way or another
Essential Questions and Answers on Programme for International Drug Monitoring in "INTERNATIONAL»INTERNATIONAL"
What is the Program for International Drug Monitoring (PIDM)?
PIDM is an international collaboration of medicines regulators, healthcare professionals and research organizations that are working together to protect public health by preventing harm caused by the wrong use of medicines. The main aim of PIDM is to identify new safety concerns associated with the use of prescription and non-prescription medicines worldwide. The program monitors adverse events, assesses safety signals, and provides global risk management advice.
Who can participate in the PIDM?
Any organisation involved in researching or regulating medicines or medical devices can join the PIDM. This includes regulatory agencies, pharmaceutical companies, universities, research institutions, patient organizations and others.
How does the PIDM work?
PIDM collects voluntary reports of adverse events from healthcare providers, researchers and patients who are using any kind of medicine such as over-the-counter drugs or prescription medications. These reports are submitted to the program’s database where they are reviewed and analyzed for possible safety risks associated with a particular medicine or class of drugs. Based on these data, action might be taken if necessary in terms of warning labels changes or bans on certain products.
Why is it important to participate in the PIDM?
Participating in this program helps ensure that increased safety assessments occur on a global scale to better protect public health from unforeseen drug-related harms or interactions. It also drives innovation through increased development efforts for existing drugs as well as future treatments and therapies. Overall, participating in the Program will help build a safer world for us all!
Are there any costs associated with joining PIDM?
There is no cost associated with joining MPIDR but members must agree to comply with certain requirements regarding reporting adverse events within their respective countries and sharing information with others in order to facilitate global risk management efforts.
Who is responsible for implementing process related changes arising from recommendations made by pidm?
Responsibility lies with the individual member countries – they are expected to take appropriate actions based on recommendations provided by pidm including updating warning labels or banning products altogether if necessary.
What types of data does pidm collect?
Pidm collects data relating to adverse events associated with prescription and non-prescription medicines worldwide. This includes reported cases concerning medication reaction severity, geographic distribution patterns among other variables monitored.
How do I report an adverse event I suspect was due to a medicine I took?
You can report an adverse event directly to your local healthcare provider or you can join one of many patient registries participating in Pidm which collect drug specific reports pertaining to post market surveillance activities